|
Survival of target tumor MDA/MB-361 cells incubated with breast cancer patients PBMC in nutrient medium with 10% pooled serum (Nc) or with 10% of autologous serum (Na) without or with 21 μg/ml Herceptin (Na+H). Effectors (E) to target tumor cells (T) ratio was 5:1. |
||||
| Patient |
S N (%) |
S Na (%) |
S Na+H (%) |
CD16 (%) |
|
|
||||
| 1 |
73 |
30 |
21 |
32.02 |
| 2 |
42 |
39 |
13 |
18.98 |
| 3 |
73 |
69 |
30 |
16.68 |
| 4 |
49 |
27 |
24 |
25.76 |
| 5 |
87 |
23 |
12 |
ND |
| 6 |
69 |
62 |
49 |
ND |
| 7 |
55 |
33 |
5 |
28.00 |
| 8 |
53 |
11 |
8 |
25.32 |
| 9 |
49 |
40 |
11 |
5.47 |
| 10 |
51 |
57 |
33 |
4.84 |
| 11 |
24 |
34 |
13 |
ND |
| 12 |
70 |
32 |
10 |
ND |
| 13 |
40 |
35 |
19 |
11.81 |
| 14 |
74 |
14 |
9 |
25.59 |
|
ND – non-determined | ||||
Juranic et al. Journal of Translational Medicine 2005 3:13 doi:10.1186/1479-5876-3-13 |
||||